Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 8.43% is 200% above its 2-year average of -8.47%, near the high end of its 2-year range (-38.79%–16.58%).
33.41% above its 12-month average of 6.32%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 7.36%.
NET PROFIT MARGIN
8.43%
NET PROFIT MARGIN AVG TTM
6.32%
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+33.41%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 452 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$4.92B
Net Profit Margin
-1570.85%
TTM Avg
-4668.05%
3Y Avg
-2830.27%
5Y Avg
-2034.87%
Market Cap
$5.20B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.30%
5Y Avg
-277.86%
Market Cap
$5.20B
Net Profit Margin
9.22%
TTM Avg
8.68%
3Y Avg
7.83%
5Y Avg
5.80%
Market Cap
$4.81B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.78B
Net Profit Margin
-20.73%
TTM Avg
-55.30%
3Y Avg
-87.73%
5Y Avg
-105.64%
Market Cap
$5.27B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-158.41%
Market Cap
$5.35B
Net Profit Margin
25.48%
TTM Avg
34.77%
3Y Avg
31.87%
5Y Avg
32.80%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BillionToOne, Inc. (BLLN) | $5.02B | 8.43% | 6.32% | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | -1570.85% | -4668.05% | -2830.27% | -2034.87% |
| Erasca, Inc. (ERAS)vs › | $5.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | 0.00% | 0.00% | -101.30% | -277.86% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 9.22% | 8.68% | 7.83% | 5.80% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | 0.00% | 0.00% | 0.00% | 0.00% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.78B | -20.73% | -55.30% | -87.73% | -105.64% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | 0.00% | 0.00% | 0.00% | -158.41% |
| Doximity, Inc. (DOCS)vs › | $5.35B | 25.48% | 34.77% | 31.87% | 32.80% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | -55.82% | -71.50% | -84.24% | -84.24% |
Operating Margin
10.9%
Net Profit Margin
8.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 7.36% |
| 2026-03-31 | 16.58% |
| 2025-12-31 | 6.22% |
| 2025-09-30 | 1.80% |
| 2025-06-30 | -0.37% |
| 2025-03-31 | -6.76% |
| 2024-12-31 | -25.46% |
| 2024-09-30 | -38.79% |
| 2024-06-30 | -9.18% |
| 2024-03-31 | -36.05% |